Abiopharma

News list

Mulligan Donal L 🟡 adjusted position in 2.5K shares (1 derivative) of TENNANT CO (TNC) at $78.81 Transaction Date: Apr 14, 2026 | Filing ID: 000004

Full text

News bot April 16, 2026, 8:16 p.m.
🔍 Mulligan Donal L (Executive)

Company: TENNANT CO (TNC)

Report Date: 2026-04-14
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 1
- Holdings reported: 1
- Total shares acquired: 3,538
- Total shares sold: 5,994
- Total shares held: 8,000
Detailed Transactions and Holdings:
- Acquired 3,538 shares of Common Stock at $54.7 per share (Direct)
  Date: 2026-04-14 | Code: M | equity_swap_involved: 0 | shares_owned_after: 23,141.00 | transaction_form_type: 4
- Sold 2,456 shares of Common Stock at $78.81 per share (Direct)
  Date: 2026-04-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 20,685.00 | transaction_form_type: 4
- Holds 0 shares of Common Stock (Direct)
  Date: 2026-04-14 | Code: H | nature_of_ownership: By trust for spouse | shares_owned_after: 8,000.00
- Sold 3,538 shares of Stock Option (right to buy) at $54.7 per share (Derivative)
  Date: 2026-04-14 | Code: M | Expires: 2026-04-28 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: Fully vested.